Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Assadi, Majid
Manafi-Farid, Reyhaneh
Jafai, Esmail
Keshavarz, Ahmad
Divband, GhasemAli
Moradi, Mohammad Mobin
Adinehpour, Zohreh
Samimi, Rezvan
Dadgar, Habibollah
Mayer, Benjamin
Prasad, Vikas
机构：
[1] Bushehr Univ Med Sci, Bushehr, Iran
[2] Univ Tehran Med Sci, Tehran, Iran
[3] Persian Gulf Univ, Bushehr, Iran
[4] Khatam PET CT Ctr, Tehran, Iran
[5] Shahid Beheshti Univ, Tehran, Iran
[6] Razavi Hosp, Canc Res Ctr, Mashhad, Iran
[7] Univ Ulm, Ulm, Germany
[8] Univ Hosp Ulm, Ulm, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
200
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Autio, Karen A.
    Anand, Aseem
    Krupa, Rachel
    Louw, Jessica
    Arslan, Zaina
    Dittamore, Ryan
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [42] PROGNOSTIC VALUE OF PRETREATMENT LUNG IMMUNE PROGNOSTIC INDEX IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE AND CASTRATION-RESISTANT PROSTATE CANCER
    Wang, Zhipeng
    Liu, Haoyang
    Zhao, Jinge
    Shen, Pengfei
    Zeng, Hao
    JOURNAL OF UROLOGY, 2023, 209 : E218 - E218
  • [43] Prognostic value of pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
    Wang, Z.
    Liu, H.
    Zhao, J.
    Junru, C.
    Shen, P.
    Zeng, H.
    EUROPEAN UROLOGY, 2023, 83
  • [44] PSMA PET Index - Introduction of a new imaging quantitative biomarker for assessment of osseous tumor burden in patients with metastatic castration-resistant prostate cancer
    Kroenke, M.
    Bieth, M.
    Tauber, R.
    Retz, M.
    Menze, B.
    Gschwend, J.
    Maurer, T.
    Schwaiger, M.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S343 - S343
  • [45] Comparison of 68Ga-PSMA and 177Lu-PSMA Total Metabolic Tumor Volume (TMTV) variations for monitoring metastatic castration-resistant prostate cancer in 177Lu-PSMA therapy.
    Boursier, C.
    Zaragori, T.
    Kunsch, J.
    Olivier, P.
    Claudin, M.
    Marie, P.
    Bros, M.
    Bordonne, M.
    Verger, A.
    Karcher, G.
    Imbert, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S361 - S362
  • [46] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Phase II Study with metastatic castration-resistant Prostate Cancer (mCRPC) Patients
    Rexer, H.
    Graefen, M.
    UROLOGE, 2017, 56 (11): : 1468 - 1470
  • [48] Prognostic and predictive utility of copy number variations (CNVs) in circulating tumor DNA (ctDNA) from metastatic castration-resistant prostate cancer (mCRPC) patients
    Fettke, Heidi
    Kwan, Edmond M.
    Yu, Jianjun
    Wang, Amy
    Montesinos, Carlos
    Wong, Calvin
    Gong, Xue
    Zheng, Tiantian
    Du, Peter Pan
    Jia, Shidong
    Mant, Andrew
    Parente, Phillip
    Pezaro, Carmel
    Azad, Arun A.
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer
    Fankhauser, Christian Daniel
    Poyet, Cedric
    Kroeze, Stephanie G. C.
    Kranzbuhler, Benedikt
    Schuler, Helena I. Garcia
    Guckenberger, Matthias
    Kaufmann, Philipp A.
    Hermanns, Thomas
    Burger, Irene A.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (03) : 457 - 467
  • [50] Prognostic value of novel inflammation index for patients with metastatic castration-resistant prostate cancer
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Rii, Junryo
    Yamamoto, Satoshi
    Kamada, Shuhei
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Komiya, Akira
    Nakatsu, Hiroomi
    Ichikawa, Tomohiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345